Posted by
admin in
Companies,
Mid Term Picks on
Apr 8th, 2010 |
no responses
- CMP: Rs 202
- Target Price: Rs 240
- EPS: Rs 19
- Dividend: 22%
- Book Value: Rs 135
Ankur Drugs & Pharma Ltd Stock Annalysis
- About to buy TVC Life Sciences.
- Trying for permissions to enter foriegn markets for the medicines produced through its buddy plants.
- Recently company board has decided to convert 1000 FCCBs into shares.
- In two years the Net Sales and Net profit are expected to grow by a compounded rate of 22% and 24%
Source: Sakshi Business News
The above recommendations are based on company fundamentals. We are not responsible for your investment decisions.